High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma
Backgrounds Lung adenocarcinoma is a complex disease that results in over 1.8 million deaths a year. Recent advancements in treating and managing lung adenocarcinoma have led to modest decreases in associated mortality rates, owing in part to the multifactorial etiology of the disease. Novel prognos...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2021-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/10560.pdf |